PAVmed Inc. SEC filings PAVM
PAVmed Inc. has 691 filings in SEC EDGAR's recent list, going back to Nov 19, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (material agreement, change to shareholder rights). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Feb 24, 2026 | Feb 24, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 13, 2026 | Feb 13, 2026 |
| DEF 14A | Proxy statement | Oct 31, 2025 | Oct 31, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 20, 2025 | Oct 20, 2025 |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jan 7, 2025 | — |
| DEF 14A | Proxy statement | Dec 6, 2024 | Dec 6, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 21, 2024 | Nov 21, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 19, 2023 | Apr 19, 2023 |
| DEF 14A | Proxy statement | Feb 21, 2023 | Feb 21, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 8, 2023 | Feb 8, 2023 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | May 2, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2022 | Apr 22, 2022 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Apr 30, 2021 |
| DEF 14A | Proxy statement | Jan 27, 2021 | Jan 27, 2021 |
| PRE 14A | Preliminary proxy statement | Jan 15, 2021 | Jan 15, 2021 |
| DEF 14A | Proxy statement | Jun 11, 2020 | Jun 11, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 1, 2020 | Jun 1, 2020 |
| DEFA14A | Additional proxy material | May 20, 2019 | — |
| DEF 14A | Proxy statement | Apr 30, 2019 | Apr 30, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2019 | Apr 19, 2019 |
| DEF 14A | Proxy statement | Aug 24, 2018 | Aug 24, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 10, 2018 | Aug 10, 2018 |
| DEF 14A | Proxy statement | Aug 30, 2017 | Aug 30, 2017 |
| DEF 14C | Information statement | May 1, 2017 | May 1, 2017 |
| PRE 14C | Preliminary information statement | Apr 10, 2017 | Apr 10, 2017 |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PAVM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1624326
- Former names
- PAXmed Inc. (until Mar 26, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.